Dr. Stephen Smith, founder of the Smith Center for Infectious Diseases and Urban Health in East Orange, New Jersey, said the remarkable results he is seeing in his coronavirus patients using a combination of the anti-malaria drug hydroxychloroquine and the antibiotic azithromycin marks the "Beginning of the end" of the COVID-19 pandemic.
"I think this is the beginning of the end of the pandemic. I'm very serious," said Smith, whose facility is in the New York metropolitan area, the U.S. hotspot for the coronavirus outbreak.
Dr. Mehmet Oz told Fox News host Sean Hannity on Wednesday that the Chinese have conducted a "Randomized trial" with hydroxychloroquine after noticing that none of the patients taking the drug for lupous and rheumatoid arthritis were contracting the coronavirus.
99%. 1%. The study consisted of 62 COVID-19 patients in which researchers gave half of them hydroxychloroquine over a five-day period, Oz said.
He said New York-Presbyterian Hospital, where he works as a surgeon, has launched a study among its staff to see if taking hydroxychloroquine has a prophylactic effect of keeping people from developing the illness.
On Sunday, the Food and Drug Administration issued an emergency use authorization for hydroxychloroquine to treat coronavirus patients.
President Donald Trump has said he sees the drug as a potential "Game-changer" in the fight against COVID-19.
https://www.westernjournal.com/medical-expert-sees-beginning-end-coronavirus-fight-new-treatment-results/
"I think this is the beginning of the end of the pandemic. I'm very serious," said Smith, whose facility is in the New York metropolitan area, the U.S. hotspot for the coronavirus outbreak.
Dr. Mehmet Oz told Fox News host Sean Hannity on Wednesday that the Chinese have conducted a "Randomized trial" with hydroxychloroquine after noticing that none of the patients taking the drug for lupous and rheumatoid arthritis were contracting the coronavirus.
99%. 1%. The study consisted of 62 COVID-19 patients in which researchers gave half of them hydroxychloroquine over a five-day period, Oz said.
He said New York-Presbyterian Hospital, where he works as a surgeon, has launched a study among its staff to see if taking hydroxychloroquine has a prophylactic effect of keeping people from developing the illness.
On Sunday, the Food and Drug Administration issued an emergency use authorization for hydroxychloroquine to treat coronavirus patients.
President Donald Trump has said he sees the drug as a potential "Game-changer" in the fight against COVID-19.
https://www.westernjournal.com/medical-expert-sees-beginning-end-coronavirus-fight-new-treatment-results/
No comments:
Post a Comment